Colorectal

The A.R.CA.D colorectal cancer program is based on an international database of 63 therapeutic clinical trials on metastatic colorectal cancer (mCRC). It brings together around 50,000 individual data on patients, diseases, treatments and results.

The colorectal database (mCRC) was created in 2007 to improve the management and evaluation of drugs for patients with metastatic colorectal cancer, and ultimately improve and accelerate regulatory approvals.

In 2020, the Foundation partnered with the National Cancer Center Hospital East (Kashiwa, Japan). The Mayo Clinic (Rochester, Minnesota, United States) worked on improving the base data management since 2023.

The analyzes carried out by statisticians based in France, the United States and Japan on the mCRC database aim to demonstrate and standardize new criteria for evaluating the effectiveness of treatments.

The A.R.CA.D colorectal program is opened to all centers across the world, whether private or public. Investigators are requested to include all their operated patients consecutively and to provide their follow-up on a long-term basis.